Skip to main content
Premium Trial:

Request an Annual Quote

DNA Sciences, Germany s Merck Group in Pharmacogenomics Alliance

NEW YORK, Sept. 4-The California company DNA Sciences said today that it had struck a pharmacogenomics research collaboration with Germany's Merck Group.


Researchers from the two companies will work together to identify DNA variants associated with different drug responses. The team will then analyze allele frequencies of those genes in three separate ethnic groups.


Merck Group (Merck KGaA) is an international pharmaceutical and chemical manufacturer based in Darmstadt, Germany.


DNA Sciences, based in Fremont, Calif., develops and markets DNA-based diagnostics and pharmacogenomic techniques.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.